198 related articles for article (PubMed ID: 15082724)
1. Factors associated with breast cancer clinical trials participation and enrollment at a large academic medical center.
Simon MS; Du W; Flaherty L; Philip PA; Lorusso P; Miree C; Smith D; Brown DR
J Clin Oncol; 2004 Jun; 22(11):2046-52. PubMed ID: 15082724
[TBL] [Abstract][Full Text] [Related]
2. Barriers to therapeutic clinical trials enrollment: differences between African-American and white cancer patients identified at the time of eligibility assessment.
Penberthy L; Brown R; Wilson-Genderson M; Dahman B; Ginder G; Siminoff LA
Clin Trials; 2012 Dec; 9(6):788-97. PubMed ID: 23033547
[TBL] [Abstract][Full Text] [Related]
3. The impact of socioeconomic status and race on trial participation for older women with breast cancer.
Gross CP; Filardo G; Mayne ST; Krumholz HM
Cancer; 2005 Feb; 103(3):483-91. PubMed ID: 15597407
[TBL] [Abstract][Full Text] [Related]
4. Participation in cancer clinical trials: race-, sex-, and age-based disparities.
Murthy VH; Krumholz HM; Gross CP
JAMA; 2004 Jun; 291(22):2720-6. PubMed ID: 15187053
[TBL] [Abstract][Full Text] [Related]
5. Investigating potential disparities in clinical trial eligibility and enrollment at an NCI-designated comprehensive cancer center.
Patel MA; Shah JL; Brinley FJ; Abrahamse PH; Veenstra CM; Schott AF
Cancer Med; 2023 Jun; 12(11):12802-12812. PubMed ID: 37151163
[TBL] [Abstract][Full Text] [Related]
6. Increasing minority patient participation in cancer clinical trials using oncology nurse navigation.
Holmes DR; Major J; Lyonga DE; Alleyne RS; Clayton SM
Am J Surg; 2012 Apr; 203(4):415-22. PubMed ID: 21996347
[TBL] [Abstract][Full Text] [Related]
7. Racial/ethnic differences in clinical trial enrollment, refusal rates, ineligibility, and reasons for decline among patients at sites in the National Cancer Institute's Community Cancer Centers Program.
Langford AT; Resnicow K; Dimond EP; Denicoff AM; Germain DS; McCaskill-Stevens W; Enos RA; Carrigan A; Wilkinson K; Go RS
Cancer; 2014 Mar; 120(6):877-84. PubMed ID: 24327389
[TBL] [Abstract][Full Text] [Related]
8. Accrual to breast cancer clinical trials at a university-affiliated hospital in metropolitan Detroit.
Simon MS; Brown DR; Du W; LoRusso P; Kellogg CM
Am J Clin Oncol; 1999 Feb; 22(1):42-6. PubMed ID: 10025379
[TBL] [Abstract][Full Text] [Related]
9. Discussions about clinical trials among patients with newly diagnosed lung and colorectal cancer.
Kehl KL; Arora NK; Schrag D; Ayanian JZ; Clauser SB; Klabunde CN; Kahn KL; Fletcher RH; Keating NL
J Natl Cancer Inst; 2014 Oct; 106(10):. PubMed ID: 25217775
[TBL] [Abstract][Full Text] [Related]
10. Cancer trials versus the real world in the United States.
Al-Refaie WB; Vickers SM; Zhong W; Parsons H; Rothenberger D; Habermann EB
Ann Surg; 2011 Sep; 254(3):438-42; discussion 442-3. PubMed ID: 21775882
[TBL] [Abstract][Full Text] [Related]
11. Outcomes of a cancer clinical trial matching service.
Gansler T; Jin M; Bauer J; Dahlquist K; Tis L; Sharpe K; Comis R; Naples K; Kepner J
J Cancer Educ; 2012 Mar; 27(1):11-20. PubMed ID: 22131066
[TBL] [Abstract][Full Text] [Related]
12. Not immune to inequity: minority under-representation in immunotherapy trials for breast and gynecologic cancers.
Grette KV; White AL; Awad EK; Scalici JM; Young-Pierce J; Rocconi RP; Jones NL
Int J Gynecol Cancer; 2021 Nov; 31(11):1403-1407. PubMed ID: 34088749
[TBL] [Abstract][Full Text] [Related]
13. Who enrolls onto clinical oncology trials? A radiation Patterns Of Care Study analysis.
Movsas B; Moughan J; Owen J; Coia LR; Zelefsky MJ; Hanks G; Wilson JF
Int J Radiat Oncol Biol Phys; 2007 Jul; 68(4):1145-50. PubMed ID: 17418963
[TBL] [Abstract][Full Text] [Related]
14. A surveillance system for monitoring, public reporting, and improving minority access to cancer clinical trials.
Carpenter WR; Tyree S; Wu Y; Meyer AM; DiMartino L; Zullig L; Godley PA
Clin Trials; 2012 Aug; 9(4):426-35. PubMed ID: 22761398
[TBL] [Abstract][Full Text] [Related]
15. Age-, sex-, and race-based differences among patients enrolled versus not enrolled in acute lung injury clinical trials.
Cooke CR; Erickson SE; Watkins TR; Matthay MA; Hudson LD; Rubenfeld GD
Crit Care Med; 2010 Jun; 38(6):1450-7. PubMed ID: 20386308
[TBL] [Abstract][Full Text] [Related]
16. A prospective analysis of the influence of older age on physician and patient decision-making when considering enrollment in breast cancer clinical trials (SWOG S0316).
Javid SH; Unger JM; Gralow JR; Moinpour CM; Wozniak AJ; Goodwin JW; Lara PN; Williams PA; Hutchins LF; Gotay CC; Albain KS
Oncologist; 2012; 17(9):1180-90. PubMed ID: 22723506
[TBL] [Abstract][Full Text] [Related]
17. Cartographic Mapping and Travel Burden to Assess and Develop Strategies to Improve Minority Access to National Cancer Clinical Trials.
Bruner DW; Pugh SL; Yeager KA; Bruner J; Curran W
Int J Radiat Oncol Biol Phys; 2015 Nov; 93(3):702-9. PubMed ID: 26281827
[TBL] [Abstract][Full Text] [Related]
18. Racial Disparities in Clinical Outcomes on Investigator-Initiated Breast Cancer Clinical Trials at an Urban Medical Center.
Aldrich J; Ekpo P; Rupji M; Switchenko JM; Torres MA; Kalinsky K; Bhave MA
Clin Breast Cancer; 2023 Jan; 23(1):38-44. PubMed ID: 36333193
[TBL] [Abstract][Full Text] [Related]
19. Factors associated with receipt of breast cancer adjuvant chemotherapy in a diverse population-based sample.
Griggs JJ; Hawley ST; Graff JJ; Hamilton AS; Jagsi R; Janz NK; Mujahid MS; Friese CR; Salem B; Abrahamse PH; Katz SJ
J Clin Oncol; 2012 Sep; 30(25):3058-64. PubMed ID: 22869890
[TBL] [Abstract][Full Text] [Related]
20. Racial and ethnic disparities in the use of postmastectomy breast reconstruction: results from a population- based study.
Alderman AK; Hawley ST; Janz NK; Mujahid MS; Morrow M; Hamilton AS; Graff JJ; Katz SJ
J Clin Oncol; 2009 Nov; 27(32):5325-30. PubMed ID: 19805680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
